Sex differences in adolescent methylphenidate sensitization: Effects on glial cell-derived neurotrophic factor and brain-derived neurotrophic factor

Behavioural Brain Research

Volumn 273, Issue , 2014, Pages 139-143

  Roeding, Ross L ^a   Perna, Marla K ^a   Cummins, Elizabeth D ^a   Peterson, Daniel J ^a   Palmatier, Matthew I ^a   Brown, Russell W ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Adolescence; Brain derived neurotrophic factor; Glial cell derived neurotrophic factor; Methylphenidate; Sensitization

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; METHYLPHENIDATE; SODIUM CHLORIDE; CENTRAL STIMULANT AGENT;

ADOLESCENT HEALTH; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG SENSITIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HABITUATION; HUMAN; HYPERACTIVITY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; AGE; ANIMAL; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY;

AGE FACTORS; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MALE; METHYLPHENIDATE; MOTOR ACTIVITY; RATS; SEX FACTORS;

EID: 84905827607     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.07.014     Document Type: Article

References (22)

1. Garland E.J. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats. J Psychopharmacol 1998, 12:385-395.
2. Volkow N.D., Ding Y., Fowler J.S., Wang G.J., Logan J., Gatley J.S., et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in human brain. Arch Gen Psychiatr 1995, 52:456-463.
3. Kollins S.H., MacDonald E.K., Rush C.R. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol Biochem Behav 2001, 68:611-627.
4. Dupont R.L., Coleman J.J., Bucher R.H., Wilford B.B. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addict 2008, 17:167-171.
5. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 2000, 151:99-120.
6. Brown R.W., Hughes B.A., Hughes A.B., Sheppard A.B., Perna M.K., Ragsdale W.L., et al. Sex and dose-related differences in methylphenidate adolescent locomotor sensitization and effects on brain-derived neurotrophic factor. J Psychopharmacol 2012, 26:1480-1488.
7. Horger B.A., Iyasere C.A., Berhow M.T., Messer C.J., Nestler E.J., Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 1999, 19:4110-4122.
8. Fanous S., Lacagnina M.J., Nikulina E.M., Hammer R.P. Sensitized activation of Fos and brain-derived neurotrophic factor in the medial prefrontal cortex and ventral tegmental area accompanies behavioral sensitization to amphetamine. Neuropharmacology 2011, 61:558-564.
9. Reichardt L.F. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 2006, 361:1545-1564.
10. Airaksinen M.S., Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 2002, 3:383-394.
11. Lu L., Wang X., Wu P., Xu C., Zhao M., Morales M., et al. Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biol Psychiatr 2009, 66:137-145.
12. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci 2003, 23:742-747.
13. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 1997, 25:192-216.
14. Volkow N.D., Wang G.J., Fowler J.S., Tomasi D., Telang F. Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci USA 2011, 108:15037-15042.
15. Chelaru M.I., Yang P.B., Dafny N. Sex differences in the behavioral response to methylphenidate in three adolescent rat strains (WKY, SHR. SD). Behav Brain Res 2012, 226:8-17.
16. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 1999, 64:803-812.
17. Andersen S.L., Teicher M.H. Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev 2000, 24:137-141.
18. Smith R.F. Animal models of periadolescent substance abuse. Neurotoxicol Teratol 2003, 25:291-293.
19. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000, 24:417-463.
20. Wooters T.E., Dwoskin L.P., Bardo M.T. Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology 2006, 188:18-27.
21. Rangasamy S.B., Soderstrom K., Bakay R.A., Kordower J.H. Neurotrophic factor therapy for Parkinson's disease. Prog Brain Res 2010, 184:237-264.
22. Bahi A., Boyer F., Chandrasekar V., Dreyer J.L. Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference, and reinstatement in rats. Psychopharmacology (Berl) 2008 Aug, 199(2):169-182.